NutriBand (NTRB) Share-based Compensation (2017 - 2026)
NutriBand's (NTRB) quarterly Share-based Compensation came in at $1.4 million in Q1 2026, up 20.76% quarter-over-quarter from $1.1 million in Q4 2025.
NutriBand (NTRB) Share-based Compensation (2017 - 2026) Analysis & Trends
NutriBand has disclosed Share-based Compensation across 10 years of filings, most recently posting $1.4 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $1.4 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was $2.6 million (up 1875.25% YoY), and the FY2026 annual result was $2.6 million, up 1875.25% from the prior year.
- Share-based Compensation came in at $1.4 million for Q1 2026 at NutriBand, up from $1.1 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.4 million in Q1 2026 to a low of -$1.9 million in Q1 2022.
- The 5-year median for Share-based Compensation is $167810.0 (2023), against an average of $155439.8.
- Peak annual rise in Share-based Compensation reached 463.71% in 2024, while the deepest fall reached 350.27% in 2024.
- NutriBand's Share-based Compensation stood at $312121.0 in 2022, then sank by 46.24% to $167810.0 in 2023, then slumped by 350.27% to -$419985.0 in 2024, then jumped by 372.83% to $1.1 million in 2025, then increased by 20.76% to $1.4 million in 2026.
- The last three Share-based Compensation figures came in at $1.4 million (Q1 2026), $1.1 million (Q4 2025), and $41050.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 305,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26.47 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 1.38 Mn |
| Jan 31, 2026 | 1.38 Mn |
| Oct 31, 2025 | 1.15 Mn |
| Oct 31, 2025 | 1.15 Mn |
| Jul 31, 2025 | 41,050.00 |
| Jul 31, 2025 | 41,050.00 |
| Apr 30, 2025 | 63,350.00 |
| Apr 30, 2025 | 63,350.00 |
| Oct 31, 2024 | -419,985.00 |
| Oct 31, 2024 | -419,985.00 |
| Jul 31, 2024 | 130,380.00 |
| Jul 31, 2024 | 130,380.00 |
| Apr 30, 2024 | 422,955.00 |
| Apr 30, 2024 | 422,955.00 |
| Jan 31, 2024 | 257,016.00 |
| Jan 31, 2024 | 257,016.00 |
| Oct 31, 2023 | 167,810.00 |
| Oct 31, 2023 | 167,810.00 |
| Apr 30, 2023 | 75,030.00 |
| Apr 30, 2023 | 75,030.00 |